24–25 Nov 2026
IARC
Europe/Paris timezone

Session

Prevention Interventions, Policy & Public Health Impact

T3
25 Nov 2026, 13:30
RC 150 - Auditorium (IARC)

RC 150 - Auditorium

IARC

25 avenue Tony Garnier, Lyon, France

Presentation materials

There are no materials yet.

  1. Oliver Langselius (IARC)
    25/11/2026, 13:30
    Prevention Interventions, Policy & Public Health Impact
    Extended oral

    Background: Gastric cancer is one of the most common and deadly cancers globally and most cases are attributable to modifiable risk factors, particularly Helicobacter pylori infections. Survival remains low globally and varies between populations. We estimate the current and future avoidable deaths among people diagnosed with gastric cancer in 2024 to inform targeted gastric cancer...

    Go to contribution page
  2. Reisya Rizki Riantiningtyas (Institut Lyfe Research and Innovation Centre, 69130 Ecully, France)
    25/11/2026, 13:50
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Background: Sensory alterations and oral symptoms are common among patients undergoing cancer treatment and can negatively affect food intake, eating enjoyment, and quality of life. This study aimed to develop and evaluate sensory-customised foods designed for patients with cancer.
    Methods: Food concepts were developed and evaluated through a focus group discussion involving patients with...

    Go to contribution page
  3. Juliette Artignan (IARC)
    25/11/2026, 14:05
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Background: Alcohol causes an estimated 28,000 new cancer cases annually in France. According to the World Health Organisation, comprehensive alcohol marketing restrictions are a cost-effective policy to reduce alcohol consumption. Although the Loi Évin has restricted alcohol marketing in France since 1993, its public health impact depends in part on adequate monitoring and enforcement. This...

    Go to contribution page
  4. Taylor James Cromarty (IARC)
    25/11/2026, 14:20
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Gastric cancer is the 5th most common cause of cancer-related deaths worldwide; in Europe, 5-year relative survival is under 40%. The European Commission (EC) has launched initiatives to improve the approach to cancer prevention, screening, and care, with the aim of overcoming service inequality across Europe. In 2025, EC selected The International Agency for Research on Cancer to provide the...

    Go to contribution page
  5. Lays Silva de Azevedo (IARC)
    25/11/2026, 14:45
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Background: the COVID-19 pandemic disrupted cancer care worldwide, but evidence on its impact on treatment initiation is limited. Understanding how the pandemic affected cancer care is essential to strengthen the national health system during or outside of crises. Objective: to estimate the pandemic’s impact on outpatient chemotherapy initiation in Brazil for all cancers combined and...

    Go to contribution page
  6. Yann Becker (IARC)
    25/11/2026, 15:00
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Background
    Approximately 30% of cancers in Northern Europe are attributable to modifiable risk factors, yet the preventive potential of specific public health policies remains unquantified. We aimed to estimate the number of cancers that could be prevented by implementing evidence-based tobacco, alcohol, obesity and physical activity policies in six Nordic countries.
    Methods
    Using the...

    Go to contribution page
  7. Sathishrajaa Palaniraja (IARC)
    25/11/2026, 15:15
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Introduction: Cervical cancer is the second most common cancer among women in India, contributing to one-fifth of the world's cervical cancer burden and one-quarter of related deaths. HPV vaccination of adolescent girls is the first pillar of the WHO cervical cancer elimination strategy. Population-level introduction in India has been gradual and operational evidence for school-based delivery...

    Go to contribution page
  8. Muhammad Riedha (Hospices Civils de Lyon, Public Health Department, Epidemiology and Clinical Research Unit, 69002 Lyon, France)
    25/11/2026, 15:30
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Background: Clinical Trial Data Sharing (CTDS) for secondary use could improve research transparency and reproducibility. Despite journal and regulatory mandates, actual sharing of data remains rare. While 68.6% of trials intend to share data, under 1% make de-identified datasets public upon publication. CTDS is further hindered by privacy concerns, unharmonized data, and inadequate...

    Go to contribution page
  9. Naila Aba (IARC)
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    A high-sodium, low-potassium diet is linked to increased gastric cancer risk, the fifth leading cause of cancer-related death worldwide. However, data on the identification of metabolites related to sodium or potassium exposure are limited. Thus, this study aims to identify urinary metabolites associated with 24-h urinary Sodium and Potassium excretion.

    We conducted a study within 363...

    Go to contribution page
Building timetable...